DJIA 17,826.30 -279.47 -1.54%
NASDAQ 4,931.82 -75.98 -1.52%
S&P 500 2,081.18 -23.81 -1.13%
market minute promo

Celgene (NASDAQ: CELG)

113.47 -2.89 (-2.48%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

CELG $113.47 -2.48%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $115.01
Previous Close $116.36
Daily Range $113.10 - $115.61
52-Week Range $68.38 - $129.06
Market Cap $90.8B
P/E Ratio 48.69
Dividend (Yield) $0.00 (0.0%)
Volume 6,400,768
Average Daily Volume 5,717,387
Current FY EPS $4.42

Sector

Healthcare

Industry

Drug Makers

Celgene (CELG) Description

A biopharmaceutical company primarily engaged in the discovery, development and commercialization of innovative therapies designed to treat cancer and immune-inflammatory related diseases. Website: http://www.celgene.com/

News & Commentary Rss Feed

3 Healthcare Stocks You Can Buy and Hold Forever

The healthcare sector is constantly changing, but three of our top analysts would suggest that you can safely buy and hold these three healthcare stocks forever!

These Companies Probably Won't Be Acquiring Ariad Pharmaceuticals

Celgene: A Pre-Earnings Discussion Based On Recent News

4 Big Biopharma Deals We Might See In 2015

Phase II Data for Apremilast in Beh├žet's Disease Published in The New England Journal of Medicine

Why Goldman Sachs Is Wrong About These 3 Stocks - Analyst Blog

The Best Long And Short Ideas From The 2015 UGA SMIF Stock Pitch Challenge Sponsored By Seeking Alph

The Best Long And Short Ideas From The 2015 UGA SMIF Stock Pitch Challenge Sponsored By Seeking Alpha

Trillium Therapeutics Is An Overvalued Biotech Stock

7 Trends Drug Investors Should Know

Celgene's Play In Cell-Based Therapy/Regenerative Medicine Is Very Good News For Mesoblast

Can a Small New Stem Cell Pact Move the Needle for Celgene?

See More CELG News...

CELG's Top Competitors

CELG $113.47 (-2.48%)
Current stock: CELG
AMGN $163.58 (-1.97%)
Current stock: AMGN
GILD $101.38 (-1.90%)
Current stock: GILD
BIIB $419.44 (-2.15%)
Current stock: BIIB